{"id":90350,"date":"2026-11-09T16:10:00","date_gmt":"2026-11-09T16:10:00","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/?p=90350"},"modified":"2026-11-10T02:11:01","modified_gmt":"2026-11-10T02:11:01","slug":"usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/","title":{"rendered":"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows"},"content":{"rendered":"<p dir=\"RTL\"><\/p>\n<ul type=\"disc\">\n<li><span>AZmed&#8217;s<\/span><span> FDA-cleared, clinically validated X-ray AI <\/span><span>suite<\/span><span> to be integrated into USARAD&#8217;s workflows through Nanox Marketplace<\/span>\n<\/li>\n<li style=\"margin-bottom:8pt; text-align:justify;\"><span>Expansion builds on USARAD&#8217;s existing use of AZmed AI, from acute trauma to chest X-rays, to help radiologists prioritize and read studies more efficiently <\/span>\n<\/li>\n<\/ul>\n<p align=\"justify\" style=\"text-align:justify;\"><span>PETACH TIKVA, Israel, Nov. 9, 2026 (GLOBE NEWSWIRE) &#8212; <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FlJDT03OpIP_RjUosxdtRdGaDD6Uu6n08x_a_i6Czmjgz2SRj85bhs0brnNx9GDh6erOyvld_Z3TjkilQKqFxwWrrlkDAENCpYk4g_qwxFo=\" target=\"_blank\" title=\"Nanox Imaging Ltd.\" rel=\"nofollow\">Nanox Imaging Ltd.<\/a><\/span><span> (\u201cNanox\u201d or the \u201cCompany\u201d, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its wholly owned subsidiary, <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3N6OcjWe8ItSna6JONEbZr1Yzvn2OeDtDjeU0Mhn7r55PlbVL8EVtUETN96dyWrezyLVOjzW-anIYYprLkUw6gIiuNaDmoGiGJvX2vgTFQM=\" target=\"_blank\" title=\"USARAD Holdings, Inc.\" rel=\"nofollow\">USARAD Holdings, Inc.<\/a><\/span><span> (\u201cUSARAD\u201d), <\/span><span>is expanding<\/span><span> its <\/span><span>existing <\/span><span>collaboration with <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=poo61-NRAJo9Att-dUSOGq5corSm9eWFWiinWYC9NdVJAfR8IVdQ3NNv4067q4Kdqmhfv9GnrFw0O8bIgOc1yg==\" target=\"_blank\" title=\"AZmed\" rel=\"nofollow\">AZmed<\/a><\/span><span>, a medical imaging AI company specializing in AI-powered X-ray analysis, to further integrate <\/span><span>AZmed\u2019s<\/span><span> X-ray AI solutions into USARAD\u2019s radiology workflows through Nanox Marketplace.<\/span><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=poo61-NRAJo9Att-dUSOGta70ItDlEEz9MHhkpOPnbhQyceFK6ixpYzoAIzbQpW4p54sbV8sCy5-VSW4EbtcUoJj3wHVeUiY515Kd8s7ges=\" target=\"_blank\" title=\"AZmed\u2019s\" rel=\"nofollow\">AZmed\u2019s<\/a><\/span><span> <\/span><span>Rayvolve<\/span><span> AI suite covers eight FDA-cleared findings across musculoskeletal and chest X-rays. <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p_T6N6gXy_BNBMNZKcHKQjy0-ZM4gheB8KXJmKY0UMqcsr81KBJn9kB1kSo6yeQ4KI4f8sgypBgagvlZs2xNHXa1E_IXZ0sN0nny1IEJdtgtaSGunVsVR84PUd4c03HY\" target=\"_blank\" title=\"AZtrauma\" rel=\"nofollow\">AZtrauma<\/a><\/span><span> is FDA-cleared as computer-assisted detection and diagnosis software for fractures, dislocations and joint effusions in adult and pediatric patients aged two and older. <\/span><span>AZchest<\/span><span> is FDA-cleared to <\/span><span>assist radiologists in detecting<\/span><span> and <\/span><span>localizing<\/span><span> pneumothorax, pleural effusion, consolidation<\/span><span> and <\/span><span>increased cardiothoracic ratio on frontal chest radiographs<\/span><span>. Separately, <\/span><span>Rayvolve<\/span><span> LN is FDA-cleared to assist in detecting pulmonary nodules.<\/span><span> Early this year, the <\/span><span>Rayvolve<\/span><span> AI suite was evaluated in the peer-reviewed journal Radiography in the largest published multicenter study of X-ray AI to date, covering 258,373 X-rays from 100 medical centers across 26 countries and five continents. <\/span><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><span>USARAD has worked with AZmed since 2023 and<\/span><span> already uses <\/span><span>AZmed\u2019s<\/span><span> AI, starting with <\/span><span>AZtrauma<\/span><span> for acute musculoskeletal trauma and, in 2026, extending to <\/span><span>AZchest<\/span><span> for chest X-rays. Under this agreement the suite will be further integrated into USARAD\u2019s radiology workflows, which support a large network of radiologists across the U.S., with the goal of helping them prioritize and read studies more efficiently. <\/span><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><span>AZmed\u2019s<\/span><span> AI will be delivered through <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FlJDT03OpIP_RjUosxdtRdX-7yUtXKcjJ2q5681f4DrzoKyHqSaMVl39yD6PJYg2JmeTkid8m9rYmQh0aHFK1oOKe6LX1GyAOKV0AnSIpZVh8zpiZh5CGC4j_cxWeQE2a4TZE6HyzEC1poBNag1FvA==\" target=\"_blank\" title=\"Nanox Marketplace\" rel=\"nofollow\">Nanox Marketplace<\/a><\/span><span>, which will enable automated study routing and DICOM transmission between <\/span><span>AZmed\u2019s<\/span><span> AI and connected facilities on <\/span><span>OnePacs<\/span><span>, USARAD\u2019s cloud PACS platform, so AI results reach radiologists without leaving the system they already read in. <\/span><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><span>\u201cWe have valued the results<\/span><span> of our work with AZmed<\/span><span>, so we are pleased to expand our collaboration,\u201d said Elli Yuz, Chief Executive Officer of USARAD Holdings, Inc. \u201cMaking <\/span><span>AZmed\u2019s<\/span><span> FDA-cleared X-ray AI available through Nanox Marketplace and further <\/span><span>integrated into our workflows will help our radiologists prioritize and read studies more efficiently.\u201d <\/span><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><span>\u201cAI in radiology has moved beyond point solutions, with one algorithm per finding from a different vendor,\u201d said Julien Vidal, Chief Executive Officer of AZmed. \u201cThe value now lies in end-to-end suites with FDA-cleared capabilities and published clinical evidence. A network reading at USARAD\u2019s scale is exactly where this value becomes clear.\u201d <\/span><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><span>Schedule a meeting with Nanox (booth #1759) and AZmed (booth #5509) at RSNA 2026: Nanox at <\/span><span>nanox.vision<\/span><span>\/rsna2026; AZmed at azmed.co\/events<\/span><span> <\/span><span> <\/span><\/p>\n<p><span><b>About Nanox<\/b><\/span><\/p>\n<p><span>Nanox (NASDAQ: NNOX) is focused on driving the world\u2019s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.<\/span><\/p>\n<p><span>Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.<\/span><\/p>\n<p><span>Nanox\u2019s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.<\/span><\/p>\n<p><span>The Nanox ecosystem includes Nanox.ARC X, a multi-source digital tomosynthesis system designed to make advanced 3D imaging accessible in more clinical settings; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provides access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.<\/span><\/p>\n<p><span>The Nanox.ARC X was selected as one of <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UtBC5UhM9eRfBgU6BUmDVMym1v6lRBOvPo1oIHEk9EjOrJG_ltiP7zk96CTvzenLJPf8tO5wZ25qc1n86yIwzb8RhUi5eoy24a00Q6AcH95wBlyJY5FNmRkQySZWsZz4Mw5ZDvx5_tHsoYBHTXG0AXsGGCv7al8clifZqHyWF6I=\" target=\"_blank\" title=\"TIME\u2019s Best Inventions of 2026\" rel=\"nofollow\">TIME\u2019s Best Inventions of 2026<\/a><\/span><span>.<\/span><\/p>\n<p><img decoding=\"async\" height=\"145.6px\" name=\"GNW_RichHtml_IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/2fedb975-97ef-4532-a89b-2bf77d22fe54\/image1.png\" width=\"106.81px\" data-dpi=\"220\" data-filename=\"image1.png\" \/><\/p>\n<p><span>By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. For more information, please visit <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yYTCkT6moZjOfrgLXmgv7DrSqAywwXxFg5MSfWoIgzMdgJd3HCplDA0tB48upAkUkPMvRMrCGmBPJT1_ArvkeyAoxGcdMj3ua4Y1GlQ_Yks=\" target=\"_blank\" title=\"\" rel=\"nofollow\">https:\/\/www.nanox.vision<\/a><\/span><span>.<\/span><\/p>\n<p><span><b>About USARAD<\/b><\/span><\/p>\n<p><span>USARAD is an innovative company in the field of medical imaging, bringing together leading medical experts and advanced technologies for precise and rapid diagnostic services. The company focuses on providing flexible and tailored medical imaging solutions that enable its clients to receive accurate diagnoses and subsequent appropriate treatment. For more information, please visit <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yYTCkT6moZjOfrgLXmgv7Gy_Av0NqrqqsKQCYeHo5z6vUhmJzrhQ1NyWssYXzysiQbXktzyxBh6rphMRF72dil_ofEw4ilDJvYDJvS-6XK0=\" target=\"_blank\" title=\"\" rel=\"nofollow\">https:\/\/usarad.com<\/a><\/span><span>.<\/span><\/p>\n<p><span><b>About AZmed<\/b><\/span><\/p>\n<p><span>Founded in 2018, AZmed<\/span><span> is a European MedTech company developing AI solutions for medical imaging. Its <\/span><span>Rayvolve<\/span><span> AI suite includes FDA-cleared and CE-marked tools<\/span><span>.<\/span><span> Used by more than 2,500 healthcare facilities worldwide, <\/span><span>AZmed\u2019s<\/span><span> solutions improve diagnostic consistency and operational efficiency in medical imaging. Additional resources on <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pJgMOXiZnooH9Ku9Eq6zRmtl5eQnwIaqQMXbSkmQOR7gWsHZGPPUzAiV0Gwe480wPvGeHI1OOT0p7Kgxt2rkI5PtlIK9jgApOVz4y1CFgVDDkGlIsXxCgqp9OUMWMp92J8rjk-4Gn5kllEFDmPS_Ad60w8tTLT28Rvo9i1LeZ1Qev2xeofaYG7L6kJsT0Kod\" target=\"_blank\" title=\"AI-supported fracture detection\" rel=\"nofollow\">AI-supported fracture detection<\/a><\/span><span> and <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YMrbEXu0ANOubOnlgATRlSvqw4JkwdWS6pJT2YCluQbIuyl9aRQNzJk9Ce-u0vzitakVVNDa0WOBlHHsbviABmh31VGN17-AN4-8BwePjWWgJoalC6RnY7RRhWhqDptGhhYP7UaBrTThvQ24Mw8K6ieULHULRRfrKAZEFJKghs4=\" target=\"_blank\" title=\"chest imaging\" rel=\"nofollow\">chest imaging<\/a><\/span><span> are available on <\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=poo61-NRAJo9Att-dUSOGhrkkI1hgLyEkpOIcTOfcSsAIG23Ddgab5INxnTL3jns5zqeDAz5ZgDEUkHkr9MFoA==\" target=\"_blank\" title=\"AZmed\u2019s\" rel=\"nofollow\">AZmed\u2019s<\/a><\/span><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dBLk_fMJyhUoR3hPu64k7Ldy0HonUEmjFa8aoLBRdMdlwD-1G74QrfTOv0z6GaZju76JA22E9wEgwMF54om23w==\" target=\"_blank\" title=\"website\" rel=\"nofollow\"> website<\/a><\/span><span>.<\/span><\/p>\n<p><span><b>Forward-Looking Statements<\/b><\/span><\/p>\n<p><span>This press release may contain forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this press release are forward-looking statements. Such statements include, but are not limited to, any statements relating to the initiation, timing, progress and results of the Company\u2019s research and development, manufacturing, and commercialization activities with respect to its X-ray source technology and the Nanox.ARC, the ability to realize the expected benefits of its recent acquisitions and the projected business prospects of the Company and the acquired companies. In some cases, you can identify forward-looking statements by terminology such as \u201ccan,\u201d \u201cmight,\u201d \u201cbelieve,\u201d \u201cmay,\u201d \u201cestimate,\u201d \u201ccontinue,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cshould,\u201d \u201cplan,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cexpect,\u201d \u201cpredict,\u201d \u201cpotential,\u201d or the negative of these terms or other similar expressions. Forward-looking statements are based on information the Company has when those statements are <\/span><span>made or management\u2019s good faith belief as of that\u00a0time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause actual results to differ materially from those currently anticipated include: risks related to (i) Nanox\u2019s ability to complete development of the Nanox System; (ii) Nanox\u2019s ability to successfully demonstrate the feasibility of its technology for commercial applications; (iii) Nanox\u2019s history of recurring losses and negative cash flows from operating activities, significant future commitments and the uncertainty regarding the adequacy of Nanox\u2019s liquidity to pursue its complete business objectives, and substantial doubt regarding its ability to continue as a going concern; (iv) Nanox\u2019s expectations regarding the necessity of, timing of filing for, and receipt and maintenance of, regulatory clearances or approvals regarding its technology, the Nanox.ARC and Nanox.CLOUD from regulatory agencies worldwide and its ongoing compliance with applicable quality standards and regulatory requirements; (v) Nanox\u2019s ability to realize the anticipated benefits of the acquisitions, which may be affected by, among other things, competition, brand recognition, the ability of the acquired companies to grow and manage growth profitably and retain their key employees; (vi) Nanox\u2019s ability to enter into and maintain commercially reasonable arrangements with third-party manufacturers and suppliers to manufacture the Nanox.ARC; (vii) the market acceptance of the Nanox System and the proposed pay-per-scan business model; (viii) Nanox\u2019s expectations regarding collaborations with third-parties and their potential benefits; (ix) Nanox\u2019s ability to conduct business globally; (x) changes in global, political, economic, business, competitive, market and regulatory forces; (xi) risks related to the current war between Israel and Hamas and any worsening of the situation in Israel; (xii) risks related to business interruptions resulting from the COVID-19 pandemic or similar public health crises, among other things; and (xiii) potential litigation associated with our transactions.<\/span><\/p>\n<p><span>For a discussion of other risks and uncertainties, and other important factors, any of which could cause Nanox\u2019s actual results to differ from those contained in the Forward-Looking Statements, see the section titled \u201cRisk Factors\u201d in Nanox\u2019s Annual Report on Form 20-F for the year ended December 31, 2025, and subsequent filings with the U.S. Securities and Exchange Commission. The reader should not place undue reliance on any forward-looking statements included in this press release. Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this press release to conform these statements to actual results or to changes in the Company\u2019s expectations.<\/span><\/p>\n<p><span><b>Contacts<\/b><\/span><\/p>\n<p><span><b>Media Contact:<\/b><\/span><br \/><span>Ben Shannon<\/span><br \/><span>ICR Healthcare<\/span><br \/><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FlJDT03OpIP_RjUosxdtRY370Oh3ShFszeVcFdq8iTVTx76_nUAjbyQ6ypjh9fU0KU3fDK2W9O45Vz9PC1WVWhbxGLH_eVguXT-FsT-x_9EbSerRREf75HuZCWSfL9JHe0U46_XtUJArNYYbmH41ICjijlCW6kshzV1-MV2LkUAmXNPe5p4mxOyFYw8QzP7GodiGfzIyw2dwtEpvWfKlh9B_uavTchRQy6DeYHqeYzA3aM6nuIBxtJQhD8ytsl4hRDmMrlFS_8-8P0rIuy1xyA==\" target=\"_blank\" title=\"NanoxPR@icrinc.com\" rel=\"nofollow\">NanoxPR@icrinc.com<\/a><\/span><\/p>\n<p><span><b>Investor Contact:<\/b><\/span><br \/><span>Mike Cavanaugh<\/span><br \/><span>ICR Healthcare<\/span><br \/><span><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eHSf_cZ3EpSuk-JipqjtYFbxOA43E-RDufRwUHeiXXy-mguZjKOaItk_mnisD6hyY9V5CKSFUmx-ckso1jkulpkdYNOANxEGIr8i1AnPc8c46sQ3wck2wQTiwW2joIt5l7WDdHmijlQeCEYf_WefNGLL3HgBhh_N31MCB3v5-WAViEmuKeNheJkQ2oqgPKBZIqWvS1Gno39lNCauNhnZkC-RlOVataS5lA-aRZtfyDT75Fg08GQrRgoXuz9Yo_IJeK_LgvP4zIFSqgJsZx1TZDzQU2qyyV47hG52zgKsKhlHgSnYNHLBBQI0hOa6c0RpsN_wm_ge3x0g0IdnULUMpYQhKSOccl9IpFwizVv9VSA=\" target=\"_blank\" title=\"mike.cavanaugh@icrhealthcare.com\" rel=\"nofollow\">mike.cavanaugh@icrhealthcare.com<\/a><\/span><\/p>\n<p><img alt=\"\" src='https:\/\/ml-eu.globenewswire.com\/media\/MWZmNDZjN2UtYzc3OS00Y2Q0LTgwMWMtOGJiNThlYzc5NmY0LTcwMDAyNjc2Ny0yMDI2LTExLTA5LWVu\/tiny\/NANO-X-IMAGING-LTD.png' referrerpolicy='no-referrer-when-downgrade' \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AZmed&#8217;s FDA-cleared, clinically validated X-ray AI suite to be integrated into USARAD&#8217;s workflows through Nanox Marketplace Expansion builds on USARAD&#8217;s existing use of AZmed AI, from acute trauma to chest X-rays, to help radiologists prioritize and read studies more efficiently PETACH TIKVA, Israel, Nov. 9, 2026 (GLOBE NEWSWIRE) &#8212; Nanox Imaging Ltd. (\u201cNanox\u201d or the [&#8230;]\n","protected":false},"author":1,"featured_media":90351,"comment_status":"open","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-90350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globe-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows\" \/>\n<meta property=\"og:description\" content=\"AZmed&#8217;s FDA-cleared, clinically validated X-ray AI suite to be integrated into USARAD&#8217;s workflows through Nanox Marketplace Expansion buil\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T16:10:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-10T02:11:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/11\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows.png\" \/>\n\t<meta property=\"og:image:width\" content=\"245\" \/>\n\t<meta property=\"og:image:height\" content=\"334\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows\",\"datePublished\":\"2026-11-09T16:10:00+00:00\",\"dateModified\":\"2026-11-10T02:11:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/\"},\"wordCount\":1479,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Globe Newswire\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/\",\"name\":\"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-11-09T16:10:00+00:00\",\"dateModified\":\"2026-11-10T02:11:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/","og_locale":"en_US","og_type":"article","og_title":"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows","og_description":"AZmed&#8217;s FDA-cleared, clinically validated X-ray AI suite to be integrated into USARAD&#8217;s workflows through Nanox Marketplace Expansion buil","og_url":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-11-09T16:10:00+00:00","article_modified_time":"2026-11-10T02:11:01+00:00","og_image":[{"width":245,"height":334,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/11\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows","datePublished":"2026-11-09T16:10:00+00:00","dateModified":"2026-11-10T02:11:01+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/"},"wordCount":1479,"commentCount":0,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Globe Newswire"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/","url":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/","name":"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-11-09T16:10:00+00:00","dateModified":"2026-11-10T02:11:01+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/usarad-a-nanox-company-expands-collaboration-with-azmed-to-integrate-fda-cleared-x-ray-ai-into-its-teleradiology-workflows\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/90350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=90350"}],"version-history":[{"count":1,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/90350\/revisions"}],"predecessor-version":[{"id":90352,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/90350\/revisions\/90352"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/90351"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=90350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=90350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=90350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}